Histopathological Scoring of Activated Stromal Reaction and its Associations with Tumor Molecular Subtypes and Prognosis in High-Grade Serous Ovarian Carcinoma

被引:0
|
作者
Yuan, Lin [1 ]
Guo, Ruifeng [2 ]
Wang, Chen [3 ]
Huang, Yajue [2 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Shanghai, Peoples R China
[2] Mayo Clin, Rochester, MN USA
[3] Mayo Clin, Coll Med, Rochester, MN USA
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
1225
引用
收藏
页码:1165 / 1165
页数:1
相关论文
共 50 条
  • [1] Histopathological Scoring of Activated Stromal Reaction and its Associations with Tumor Molecular Subtypes and Prognosis in High-Grade Serous Ovarian Carcinoma
    Yuan, Lin
    Guo, Ruifeng
    Wang, Chen
    Huang, Yajue
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 1165 - 1165
  • [2] Consensus on Molecular Subtypes of High-Grade Serous Ovarian Carcinoma
    Chen, Gregory M.
    Kannan, Lavanya
    Geistlinger, Ludwig
    Kofia, Victor
    Safikhani, Zhaleh
    Gendoo, Deena M. A.
    Parmigiani, Giovanni
    Birrer, Michael
    Haibe-Kains, Benjamin
    Waldron, Levi
    CLINICAL CANCER RESEARCH, 2018, 24 (20) : 5037 - 5047
  • [3] Molecular Analysis of High-Grade Serous Ovarian Carcinoma Exhibiting Low-Grade Serous Carcinoma and Serous Borderline Tumor
    Kanno, Kosuke
    Nakayama, Kentaro
    Razia, Sultana
    Islam, Sohel Hasibul
    Farzana, Zahan Umme
    Sonia, Shahataj Begum
    Sasamori, Hiroki
    Yamashita, Hitomi
    Ishibashi, Tomoka
    Ishikawa, Masako
    Imamura, Kayo
    Ishikawa, Noriyoshi
    Kyo, Satoru
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2024, 46 (09) : 9376 - 9385
  • [4] Molecular Abnormalities in Ovarian Cancer Subtypes Other than High-Grade Serous Carcinoma
    Gilks, C. Blake
    JOURNAL OF ONCOLOGY, 2010, 2010
  • [5] Molecular Management of High-Grade Serous Ovarian Carcinoma
    Punzon-Jimenez, Paula
    Lago, Victor
    Domingo, Santiago
    Simon, Carlos
    Mas, Aymara
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (22)
  • [6] Molecular Subtypes of High-Grade Serous Ovarian Cancer: The Holy Grail?
    Waldron, Levi
    Riester, Markus
    Birrer, Michael
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (10):
  • [7] Comparison of tumor progression model secretome to molecular subtypes of high-grade serous ovarian cancer
    Lanfredi, Guilherme Pauperio
    Teibo, John Oluwafemi
    Grassi, Mariana Lopes
    Masson, Ana Paula
    Faca, Vitor Marcel
    BIOPHYSICAL REVIEWS, 2021, 13 (06) : 1434 - 1435
  • [8] Role of tumor location on high-grade serous ovarian cancer prognosis
    Ay, Seval
    Ozyukseler, Deniz Tataroglu
    Basak, Mustafa
    Dulgar, Ozgecan
    Arici, Serdar
    Yildirim, Mahmut Emre
    Gumus, Mahmut
    GINEKOLOGIA POLSKA, 2022, 93 (04) : 284 - 289
  • [9] Origin and molecular pathogenesis of ovarian high-grade serous carcinoma
    Kurman, R. J.
    ANNALS OF ONCOLOGY, 2013, 24 : 16 - 21
  • [10] Evaluation of the prognostic potential of histopathological subtyping in high-grade serous ovarian carcinoma
    Zelisse, Hein S.
    Hwan, Robin A.
    van de Vijver, Marc J.
    Dijk, Frederike
    Mom, Constantijne H.
    Hooijer, Gerrit K. J.
    van Gent, Mignon D. J. M.
    Snijders, Malou L. H.
    VIRCHOWS ARCHIV, 2024, 486 (2) : 381 - 391